English
Guaifenesin for horses is used primarily as an intravenous muscle relaxant during anesthesia, although it is also included as an expectorant in some products used to manage respiratory symptoms. These distinct applications involve different formulations, doses, and levels of veterinary oversight.
During anesthesia, guaifenesin helps relax skeletal muscles and may support smoother induction, intubation, and recovery when combined with other anesthetic drugs. Oral products containing guaifenesin are intended to help loosen airway mucus.
Injectable guaifenesin must be administered by a veterinarian or under direct veterinary supervision. Owners of competition horses should also be aware that guaifenesin is classified as a Controlled Medication under FEI regulations.
Keep reading to learn how guaifenesin works in horses, when it may be used, its potential side effects and interactions, and the regulations that apply to competition horses.
Guaifenesin for Horses
Guaifenesin is an established medication with a long history of use in large-animal anesthesia. Horse owners are most likely to encounter it when a veterinarian discusses “triple drip” or another total intravenous anesthetic (TIVA) mixture combining a sedative, ketamine, and guaifenesin for surgical use.
Separately, some equine cough powders or liquids contain guaifenesin as an expectorant for respiratory support. [1][2][3]
These two uses are not interchangeable. The doses and concentrations used for anesthesia differ from those in oral expectorant products. [1]
Injectable guaifenesin is available by prescription only and is administered by a veterinarian or under direct veterinary supervision. Oral combination products may be available over the counter in some markets, but their use should still be based on veterinary-directed management for the horse’s condition.
Competition horses are also subject to additional restrictions because guaifenesin has FEI Controlled Medication status under current regulations. [1][4]
Available Forms
Available products and brand names vary by country and may change over time. Veterinary drug references describe the following forms: [1]
- Injectable guaifenesin: Prescription solutions for intravenous use in horses not intended for human consumption, including products historically sold as Guailaxin® or Guaifenject®
- Oral equine combination products: Powders or liquids that pair guaifenesin with an antihistamine such as pyrilamine or other expectorants such as potassium iodide or ammonium chloride; some have been sold over the counter
- Human oral products: Tablets, liquids, and extended-release products such as Mucinex® and generic expectorants that are not labelled for horses and should only be used under veterinary direction
No owner-administered product can substitute for veterinary anesthesia. Injectable guaifenesin must be used under veterinary care. [1]
What's your top priority with your horse's health?
What's your top priority with your horse's health?
Drug Class: Centrally Acting Muscle Relaxant / Expectorant
Guaifenesin falls into two practical drug classes, depending on how it is used: [1]
- Parenteral (IV) muscle relaxant used as an adjunct to anesthesia and chemical restraint
- Oral expectorant in some equine and human respiratory products
Guaifenesin is not a paralytic neuromuscular blocker of the type used in human operating rooms. At standard veterinary doses, it relaxes skeletal muscles while preserving the diaphragm muscle action required for breathing. Historical names include glyceryl guaiacolate and guaiphenesin, the British spelling. [1]
Other drugs used to induce equine anesthesia or in total intravenous anesthetic (TIVA) protocols include sedatives and alpha-2 agonists. In these protocols, guaifenesin primarily improves muscle relaxation to help the transition into general anesthesia. It does not provide deep surgical anesthesia on its own. [1][5][6]
Mechanism of Action
The exact muscle relaxation mechanism is not fully understood. Guaifenesin is believed to act centrally on connecting neurons in subcortical brain regions, the brainstem, and the spinal cord, reducing or blocking nerve impulse transmission.
This effect relaxes skeletal muscles, including the laryngeal and pharyngeal muscles, which can make endotracheal intubation easier. [1]
The primary actions of guaifenesin include: [1]
- Relaxes skeletal muscles
- Provides mild analgesia (pain control) and sedation
- Potentiates (strengthens) the effects of many preanesthetic and anesthetic drugs
- May briefly lower blood pressure and raise heart rate
- May increase gut motility
After a single intravenous dose given alone, horses typically become recumbent within approximately two minutes. Useful light restraint lasts only a few minutes, while muscle relaxation may continue for approximately 10 to 20 minutes. [1]
Guaifenesin is processed in the liver, and the drug is excreted in urine. While it can cross the placenta, its potential effects on the fetus are not clear. Given this, veterinary judgment is required before use during pregnancy. [1]
As an oral expectorant in humans, guaifenesin has been marketed to help thin mucus, although strong evidence of benefit is limited. Equine oral products are based on the same general principle, but owners should interpret product claims cautiously and prioritize veterinary diagnosis of coughing or respiratory disease over symptomatic treatment. [1]
Uses in Horses
In North America, labelled use of guaifenesin in horses is limited to anesthetic muscle relaxation. Label status varies by product and country. Many anesthetic protocols that combine guaifenesin with other drugs are used under veterinary judgment as part of accepted clinical practice. [1]
Adjunct to Anesthesia & Chemical Restraint
Veterinarians may use intravenous guaifenesin to: [1][5][2][6][3]
- Improve muscle relaxation during induction of general anesthesia
- Help with short procedures when combined with other injectable anesthetics
- Support field or clinic TIVA protocols, often called “triple drip” when guaifenesin is combined with ketamine and an alpha-2 agonist
- Reduce the amount of inhalant anesthetic needed when given as a continuous infusion with other drugs
The veterinarian determines whether anesthesia or chemical restraint is appropriate for a procedure. Owners should expect careful cardiorespiratory monitoring, including assessment of breathing, heart rate, blood pressure, and muscle relaxation, whenever guaifenesin is part of the anesthetic plan. [1][5]
Off-Label Uses
Off-label or extra-label use occurs when a veterinarian uses a medication in a manner not specified on its approved label, such as for a different species, condition, dose, or route.
For guaifenesin, off-label use may include oral expectorant products for respiratory signs or emergency muscle relaxation in specific toxicosis cases. These uses require veterinary direction because the formulation, route, and intended effect differ from the labelled injectable anesthetic use.
Oral Expectorant
Some oral products may be considered for horses with respiratory signs such as coughing or thick airway mucus. Because these products are used off-label, consult your veterinarian before use to determine whether they are appropriate for your horse. [1]
A veterinarian should determine the cause of coughing or nasal discharge. Bacterial or viral infection, allergies, dust exposure, and other conditions require different management or treatment plans. Expectorants do not treat the underlying cause and cannot replace rest, environmental changes, or prescribed antimicrobials when indicated. [1]
Adjunct Treatment
Guaifenesin has also been described as adjunctive treatment for severe muscle rigidity associated with tetanus and some toxicoses, such as strychnine poisoning. This use is an emergency veterinary decision and not an owner-administered treatment under any circumstances. [1]
Administration Routes
Common administration routes for guaifenesin use in horses include: [1][5][3]
- Intravenous injection or infusion: The usual route for anesthetic muscle relaxation and TIVA mixtures
- Oral: In combination powders or liquids used as expectorants
Guaifenesin is administered through a secure intravenous catheter because leakage outside the vein can irritate surrounding tissues.
Do not attempt to mix or administer intravenous guaifenesin at home. An incorrect concentration or infusion rate can cause muscle rigidity, breathing problems, low blood pressure, vein irritation, or red blood cell damage. [1]
For oral equine combination products, follow the product label and your veterinarian’s directions. Do not adapt doses from human cough medications for a horse. For horses that are difficult to medicate, use safe oral medication techniques recommended by your veterinarian. [1][4]
Storage
Store guaifenesin products according to the label.
General storage considerations include: [1]
- Keep powder containers tightly closed. Guaifenesin powder is relatively stable when exposed to light and ordinary heat below its melting point
- Aqueous solutions may precipitate if they cool below approximately 22 °C (72 °F); gentle warming and stirring usually redissolve the drug
- Fresh preparation is preferred. Some 10% solutions have been described as usable for up to approximately one week at room temperature with only slight precipitation, but always follow current product guidance
Discard any cloudy or contaminated solution, and never use an expired product. [1]
Safety Warnings & Precautions
Guaifenesin for anesthesia should only be used in a setting where the horse can be monitored and supported. Depending on the other drugs used, additional cardiorespiratory support may include blood pressure medications, oxygen, or assisted ventilation. [5][2]
Additional caution is required in the following situations: [1]
- High-concentration solutions are being prepared because they increase the risk of hemolysis
- The horse has difficult venous access or a history of thrombophlebitis
- Other drugs that strongly depress cardiac or respiratory function are used concurrently
Monitoring
During anesthetic use, the veterinary team typically monitors: [1][5]
- Depth of muscle relaxation
- Heart rate and rhythm
- Respiratory rate and effort, as well as blood gases or end-tidal gases when available
- Arterial blood pressure
- Recovery time and standing quality
For oral expectorant products, owners should monitor:
- Appetite
- Manure production
- Breathing effort
- Nasal discharge
- Changes in coughing
- Respiratory noises
Over-the-counter medications are not a substitute for veterinary care. Horses with ongoing respiratory issues or exercise intolerance require veterinary assessment. If signs worsen during guaifenesin use, stop treatment and contact your veterinarian for further direction. [1]
Contraindications
Contraindications are circumstances in which a drug should be avoided or used only with caution. For guaifenesin, the main concerns relate to drug interactions, solution concentration, and intravenous administration.
Physostigmine is contraindicated for use with guaifenesin. Similar caution may apply to other cholinesterase inhibitors, including neostigmine, pyridostigmine, and edrophonium. [1]
Concentrated intravenous solutions also require caution. Solutions containing more than approximately 5% guaifenesin have been linked to hemolysis, or breakdown of red blood cells. Very concentrated solutions may also be difficult to keep fully dissolved and have been associated with hemoglobinuria (bloody urine) or urticaria (hives) in some reports. [1]
Safety during pregnancy is not fully established. In pregnant or lactating mares, a veterinarian must determine whether the expected benefits outweigh the risks for the individual horse. [1]
Side Effects
At standard anesthetic doses, side effects are often mild and short-lived. However, close monitoring remains essential because guaifenesin is almost always administered with other potent medications. [1][5]
Possible effects include: [1][5][6]
- Mild decrease in blood pressure
- Increased heart rate
- Vein irritation or thrombophlebitis after intravenous injection
- Tissue reaction if the drug leaks outside the vein
- Hemolysis with overly concentrated solutions
Side effects related to the other drugs in the mixture may also occur after TIVA use, including: [1][5][6]
- Sedation that persists into recovery
- Ataxia (incoordination) when the horse first stands
- Low blood pressure
Recovery quality depends on the complete anesthetic plan. Some protocols that include guaifenesin produce a smooth return to standing, while others may prolong recovery compared with alternative induction medications. [5][6]
Acute Toxicity (Overdose)
The reported margin of safety for guaifenesin is approximately three times the standard dose, but overdose remains dangerous.
Signs associated with toxic levels of guaifenesin include: [1]
- Abnormal breathing pattern (apneustic breathing)
- Nystagmus (abnormal eye movements)
- Low blood pressure
- Paradoxical muscle rigidity instead of relaxation
There is no specific antidote for guaifenesin overdose. Treatment is supportive while the drug level declines. [1]
If you suspect your horse received too much guaifenesin, was given another animal’s dose, or had an adverse reaction after anesthesia:
- Move the horse to a quiet stall if it is safe to do so
- Do not give additional medication or home remedies unless directed by your veterinarian
- Contact your veterinarian immediately or call an emergency clinic if your regular veterinarian is unavailable
Call for help even if the horse initially appears normal. Prompt care is especially important if you observe breathing difficulty, collapse, severe rigidity, dark urine, or an inability to stand safely.
Drug Interactions
Drug interactions with guaifenesin have not been extensively studied.
Important practical considerations include: [1]
- Physostigmine and possibly other cholinesterase inhibitors: The manufacturer contraindicates physostigmine with guaifenesin; neostigmine, pyridostigmine, and edrophonium may raise similar concerns
- Other anesthetics and sedatives: Guaifenesin potentiates many preanesthetic and anesthetic agents, so the veterinarian must adjust the doses of companion drugs
Regulatory Status & Legal Considerations
Injectable guaifenesin products are approved for use in horses as part of protocols to induce general anesthesia. Oral equine combination expectorant products that contain guaifenesin may be available over the counter in some markets.
Although human products are widely available, they are not labelled for horses and should not be used without veterinary direction. [1]
Racing regulators may classify guaifenesin as a restricted substance. The ARCI Uniform Classification Guidelines list guaifenesin, also called glycerol guaiacolate, as a Class 4 substance with a Class C penalty. [7]
Status in Competition
Guaifenesin appears on the FEI Equine Prohibited Substances List as a Controlled Medication, classified as an “Expectorant.” It may have a legitimate medical use, but it is prohibited during FEI competition and must be fully cleared according to a veterinarian-planned withdrawal interval before the horse competes. [4]
Guaifenesin does not appear on the FEI List of Detection Times. [8] Detection times are not equivalent to withdrawal times. When no detection time is published, the treating veterinarian must establish a withdrawal plan based on the dose, route, individual horse, and an appropriate safety margin.
This classification reflects guaifenesin’s therapeutic use as an expectorant, but competition timing also matters after surgery or other procedures involving anesthesia. Horses that receive guaifenesin as part of an anesthetic protocol may still require an appropriate withdrawal interval before returning to competition.
Medical fitness should also be considered separately from drug clearance. A horse recovering from surgery, injury, illness, or anesthesia may not be ready to compete even after the medication is no longer detectable or prohibited under competition rules.
National federations and racing authorities may have their own rules and testing thresholds. Check both the current FEI list and your sport’s regulations before treating a competition horse. [4][8]
Frequently Asked Questions
Here are some frequently asked questions about guaifenesin use in horses:
Guaifenesin is primarily used in horses as an intravenous muscle relaxant during anesthesia or chemical restraint. Veterinarians often combine it with ketamine and an alpha-2 agonist in total intravenous anesthesia protocols. Some oral equine products also contain guaifenesin as an expectorant intended to loosen airway mucus, but these products do not replace diagnosis and treatment of the underlying respiratory problem. [1][2][5]
Guaifenesin is primarily a centrally acting muscle relaxant in horses, although it also has mild sedative and pain-dulling effects. It does not provide enough anesthesia by itself for most surgical procedures. Veterinarians combine it with sedatives and anesthetic drugs to achieve suitable restraint, unconsciousness, and pain control. [1]
Guaifenesin works in horses by reducing nerve-impulse transmission in areas of the brain, brainstem, and spinal cord involved in maintaining skeletal muscle tone. This central action relaxes muscles in the body, including the laryngeal and pharyngeal muscles, which can make intubation easier. It also strengthens the effects of many sedatives and anesthetic drugs used alongside it. [1] It is included in some combination expectorant products as a mucus thinning agent, but evidence of its effects for this purpose is limited.
Veterinarians use the term "triple drip" in reference to an intravenous anesthetic mixture that typically combines a sedative, an alpha-2 agonist, and guaifenesin. Guaifenesin provides muscle relaxation, while the other drugs supply sedation, unconsciousness, and additional analgesia. Veterinarians may use this type of total intravenous anesthesia for certain short procedures in a clinic or field setting. [1][3][5]
Guaifenesin should not be used as the only anesthetic for procedures requiring surgical anesthesia in horses. Although it relaxes muscles and has mild sedative and analgesic properties, it does not reliably produce the depth of unconsciousness and pain control needed for surgery. It is used as an adjunct to drugs such as ketamine, alpha-2 agonists, or inhalant anesthetics. [1][2][4]
Guaifenesin generally preserves diaphragmatic breathing when used at usual veterinary doses in horses. However, it is commonly administered with other drugs that can depress breathing or cardiovascular function. The veterinary team must monitor respiratory effort, blood pressure, heart rate, and anesthetic depth and provide oxygen or assisted ventilation when necessary. [1][2]
Guaifenesin is administered intravenously when used for muscle relaxation and anesthesia in horses. It may be given as an injection or continuous infusion, often in a veterinary mixture containing other anesthetic drugs. Oral combination powders or liquids may be used as expectorants, but owners should follow the product label and their veterinarian's guidance. [1][2][5]
Oral guaifenesin may be included in equine respiratory products as an expectorant intended to loosen airway mucus. Its suitability depends on why the horse is coughing, and evidence for its expectorant benefit is limited. A veterinarian should investigate persistent coughing or nasal discharge because infection, equine asthma, allergies, dust exposure, and other conditions require different management or treatment. [1]
Horses should not receive human guaifenesin products such as Mucinex® unless a veterinarian has specifically prescribed them. Human tablets, liquids, and extended-release products are not labelled for horses, and combination products may contain additional ingredients that are unsuitable. Human dosing instructions also cannot be transferred safely to horses. [1]
Side effects of guaifenesin in horses can include a mild decrease in blood pressure, an increased heart rate, vein irritation, and thrombophlebitis. Leakage outside the vein can irritate surrounding tissue, while overly concentrated intravenous solutions may damage red blood cells. Sedation, poor coordination, or a prolonged recovery may also occur because guaifenesin is usually administered with other anesthetic drugs. [1][2][4]
Signs of guaifenesin overdose in horses can include an abnormal breathing pattern, involuntary eye movements, low blood pressure, and paradoxical muscle rigidity. Severe weakness, collapse, breathing difficulty, dark urine, or an inability to stand safely also requires immediate veterinary attention. There is no specific antidote, so treatment consists of supportive care until the drug is cleared. [1]
If a horse has a bad reaction to guaifenesin, contact a veterinarian or emergency clinic immediately. Do not give additional medications or home remedies unless directed by the veterinarian, and keep the horse in a quiet, safe area if it can be moved without risk. Breathing difficulty, collapse, severe rigidity, dark urine, injection-site swelling, or unsafe attempts to stand are urgent warning signs. [1]
Guaifenesin is not generally intended for long-term daily use in horses. Its anesthetic use is limited to the period surrounding a procedure, while oral expectorant products are typically used for a defined respiratory problem under veterinary guidance. A cough that persists or returns needs veterinary reassessment rather than indefinite expectorant use. [1]
The safety of guaifenesin in pregnant or nursing mares has not been fully established. Guaifenesin can cross the placenta, although standard veterinary references have not described clear evidence of harm to newborn foals from maternal use. A veterinarian should use it only when the expected benefits outweigh the potential risks. [1]
Guaifenesin should not be combined with physostigmine because manufacturer guidance identifies this interaction as a contraindication. Other cholinesterase inhibitors, including neostigmine, pyridostigmine, and edrophonium, may raise similar concerns. Guaifenesin also strengthens the effects of many sedatives and anesthetics, so the veterinarian must adjust companion drugs and monitor the horse closely. [1]
Guaifenesin should be avoided with physostigmine and used cautiously when vein access is difficult or the horse has a history of thrombophlebitis. Concentrated intravenous solutions and accidental injection outside the vein increase the risks of red blood cell damage and tissue irritation. Injectable products labelled for horses are also generally not intended for animals that may enter the human food chain. [1]
Guaifenesin is an FEI Controlled Medication rather than a Banned Substance. It may have a legitimate therapeutic use, but it must not be present in a horse during an FEI competition. Racing authorities and national equestrian federations may apply different rules, so owners should check the regulations governing their event. [6]
The withdrawal period for guaifenesin before horse competition must be determined by the treating veterinarian. Guaifenesin does not appear on the FEI List of Detection Times 2024, so there is no published FEI detection time that can be directly converted into a withdrawal plan. The veterinarian must consider the dose, route, treatment circumstances, individual horse, and an appropriate safety margin while also checking the current rules of the relevant federation or racing authority. [6][7]
Summary
Guaifenesin has two distinct uses in horses: intravenous muscle relaxation during anesthesia and oral expectorant use in some respiratory products. These uses are not interchangeable, and both require appropriate veterinary guidance.
- Injectable guaifenesin is used by veterinarians to support muscle relaxation during anesthesia
- It is commonly combined with ketamine, alpha-2 agonists, or other anesthetic drugs
- Guaifenesin does not provide deep surgical anesthesia on its own
- Some oral products include guaifenesin as an expectorant for airway mucus
- Expectorants do not treat the underlying cause of coughing or respiratory disease
- IV use requires careful dosing, dilution, catheter placement, and cardiorespiratory monitoring
- Guaifenesin is an FEI Controlled Medication, so competition timing must be planned carefully
References
- Budde. J. A. and McCluskey. D. M. Plumb's Veterinary Drug Handbook, 10th Edition. Wiley-Blackwell. 2023.
- Taylor. P. M. et al. Cardiovascular Effects of Surgical Castration During Anaesthesia Maintained with Halothane or Infusion of Detomidine, Ketamine and Guaifenesin in Ponies. Equine Veterinary Journal. 1998.
- Thakur. B. P. S. et al. Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines. Veterinary Medicine International. 2011.
- 2026 Equine Prohibited Substances List. Fédération Equestre Internationale. 2026.
- Yamashita. K. et al. Combination of Continuous Intravenous Infusion Using a Mixture of Guaifenesin-Ketamine-Medetomidine and Sevoflurane Anesthesia in Horses. Journal of Veterinary Medical Science. 2000.
- Tokushige. H. et al. A Retrospective Comparison of Induction with Thiopental/Guaifenesin and Propofol/Ketamine in Thoroughbred Racehorses Anesthetized with Sevoflurane and Medetomidine During Arthroscopic Surgery. Journal of Equine Science. 2019.
- Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule, Version 18.0. Association of Racing Commissioners International. 2024.
- FEI List of Detection Times. Fédération Equestre Internationale. 2024.
